Buffalo, New York, United States The main office of represented VC is situated in the Buffalo. The company was established in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Diagnostics, Health Care. Among the various public portfolio startups of the fund, we may underline Lineagen
The important activity for fund was in 2013. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 9 partakers. Despite the Archipel Capital, startups are often financed by Sanderling Ventures, PrairieGold Venture Partners, Mesa Verde Venture Partners. The meaningful sponsors for the fund in investment in the same round are University Venture Fund, Signal Peak Ventures, Sanderling Ventures. In the next rounds fund is usually obtained by University Venture Fund, Signal Peak Ventures, Sanderling Ventures.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| DEG | Kansas, Overland Park, United States |
| KPMG Capital | Chicago, Illinois, United States |
| Mangrove | Rotterdam, The Netherlands, Zuid-Holland |
| New Access Capital | China, Shanghai |
| Philotegy Capital | China, Shanghai |
| SANYO Semiconductor | Japan, Moriguchi, Osaka Prefecture |
| Sinar Mas Digital Ventures | Indonesia, Jakarta, Jakarta Raya |
| Uplift | District of Zvolen, Region of Banská Bystrica, Slovakia |
| Yunda Express | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lineagen | $12M | 26 Jan 2015 | Salt Lake City, Utah, United States | ||
Lineagen | $3M | 18 Dec 2013 | Salt Lake City, Utah, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lineagen | $12M | 26 Jan 2015 | Salt Lake City, Utah, United States | ||
Lineagen | $3M | 18 Dec 2013 | Salt Lake City, Utah, United States |
